(Q39829288)

15 September 2017

title

Critical care: advances and future perspectives (English)

1 reference

15 September 2017

2

1 reference

15 September 2017

1

Jean-Louis Vincent

1 reference

15 September 2017

language of work or name

English

0 references

publication date

11 October 2010

1 reference

15 September 2017

1 reference

15 September 2017

volume

376

1 reference

15 September 2017

issue

9749

1 reference

15 September 2017

page(s)

1354-1361

1 reference

Admission source to the medical intensive care unit predicts hospital death independent of APACHE II score

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Critical care without walls

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Sepsis in European intensive care units: results of the SOAP study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Mortality and length-of-stay outcomes, 1993-2003, in the binational Australian and New Zealand intensive care adult patient database

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Induced hypothermia and fever control for prevention and treatment of neurological injuries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Sepsis: rethinking the approach to clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Multicenter, randomized, controlled trials evaluating mortality in intensive care: doomed to fail?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Increased mortality associated with growth hormone treatment in critically ill adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Noninvasive positive-pressure ventilation for respiratory failure after extubation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Intensive insulin therapy and pentastarch resuscitation in severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Intensive versus conventional glucose control in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Is the current management of severe sepsis and septic shock really evidence based?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Improvement in Process of Care and Outcome After a Multicenter Severe Sepsis Educational Program in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Meta-analysis of hemodynamic optimization: relationship to methodological quality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Meta-analysis: Intravenous Immunoglobulin in Critically Ill Adult Patients with Sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

The use of an inflammation-modulating diet in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis of outcome data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Decontamination of the digestive tract and oropharynx in ICU patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Resuscitation of critically ill patients based on the results of gastric tonometry: a prospective, randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Intensive insulin therapy in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Activated protein C: do more survive?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Surviving sepsis--practice guidelines, marketing campaigns, and Eli Lilly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Increasing evidence that the risks of rhAPC may outweigh its benefits.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment*

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

The international PROGRESS registry of patients with severe sepsis: drotrecogin alfa (activated) use and patient outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Leukocyte and endothelial cell interactions in sepsis: relevance of the protein C pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Distinct functions of activated protein C differentially attenuate acute kidney injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Elevation of systemic oxygen delivery in the treatment of critically ill patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Perioperative total parenteral nutrition in surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Acid-suppressive medication use and the risk for hospital-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Catecholamine treatment for shock—equally good or bad?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Mortality rates for patients with acute lung injury/ARDS have decreased over time

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

How will we know patients are safer? An organization-wide approach to measuring and improving safety

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Give your patient a fast hug (at least) once a day.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Implementation of the "FASTHUG" concept decreases the incidence of ventilator-associated pneumonia in a surgical intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Medication errors: a prospective cohort study of hand-written and computerised physician order entry in the intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Physician staffing patterns and clinical outcomes in critically ill patients: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Two-year outcomes, health care use, and costs of survivors of acute respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Cognitive functioning, mental health, and quality of life in ICU survivors: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Quality of life in the five years after intensive care: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Seven lessons from 20 years of follow-up of intensive care unit survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Rehabilitation after critical illness: summary of NICE guidance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Caring for the critically ill patient. Current and projected workforce requirements for care of the critically ill and patients with pulmonary disease: can we meet the requirements of an aging population?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Effect of a multiple-site intensive care unit telemedicine program on clinical and economic outcomes: an alternative paradigm for intensivist staffing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Early goal-directed therapy in the treatment of severe sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Definitive care for the critically ill during a disaster: a framework for optimizing critical care surge capacity: from a Task Force for Mass Critical Care summit meeting, January 26-27, 2007, Chicago, IL.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Palliative care considerations in mass casualty events with scarce resources.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Hydrocortisone therapy for patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Ten reasons why we should NOT use severity scores as entry criteria for clinical trials or in our treatment decisions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Changes in collagen turnover in early acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

1 reference

7 January 2021

Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Bench-to-bedside review: Hydrogen sulfide--the third gaseous transmitter: applications for critical care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

Bench-to-bedside review: potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960575-2

7 January 2021

10.1016/S0140-6736(10)60575-2

Identifiers

DOI

1 reference

15 September 2017

1 reference